引起抑郁症患者对药物管理的偏好:离散选择实验的协议
Peng Xie1, Hui-Qin Li1, Wan-Lin Peng2
1People's Hospital of Deyang City, Deyang City, Sichuan, 618000, People's Republic of China.
Patient preference and adherence
|February 8, 2024
概括
了解患者对抗抑郁药物管理的偏好,对于改善抑郁症的坚持和治疗结果至关重要. 本研究使用离散选择实验来探索这些偏好和权衡.
科学领域:
- 精神病学和行为科学
- 卫生经济学 卫生经济学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 抑郁症显著影响生命,并造成经济成本,患者坚持抗抑郁药物治疗对于成功管理至关重要.
- 不良的坚持导致治疗失败和不良的临床结果,强调需要将患者的偏好纳入治疗决策.
- 离散选择实验 (DCE) 是量化患者偏好的宝贵工具,但之前的研究往往忽略了除了药物本身之外的因素.
研究的目的:
- 探索影响抑郁症患者抗抑郁药坚持的与药物管理相关的特征.
- 为了引起抑郁症患者如何感知和权衡不同药物管理策略之间的权衡.
- 为改善抑郁症治疗的坚持提供以患者为中心的方法.
主要方法:
- 设计了一个离散选择实验 (DCE),涉及六个属性及其水平,通过文献评论,采访和重点小组开发.
- 一个分数因数设计产生了36个选择集,分为3个块进行分析.
- 将采用混合logit模型来分析患者的偏好,支付意愿和各种药物管理属性的吸收率.
主要成果:
- 该研究概述了DCE的系统和严格的开发过程,坚持理论基础和设计原则.
- 试点测试证实了问卷的清晰度和适用于正式调查的适用性,包括介绍,社会人口统计问题和13个DCE选择集,其中有一个选择退出选项.
- 该方法旨在探索患者在药物管理中的偏好,为未来的定量分析铺平道路.
结论:
- 这项研究表明,在抑郁症治疗坚持的背景下,进行和报告DCE研究的强有力的框架.
- 这些发现将有助于更好地了解患者的偏好,使得开发更有效和个性化的抗抑郁药物管理策略成为可能.
- 通过系统地探索患者的权衡,这项研究旨在增强药物坚持和改善抑郁症患者的临床结果.
相关概念视频
01:23Antidepressant Drugs: MAOIs and Other Agents
230
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
230
01:25Antidepressant Drugs: Overview
487
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
487
01:28Drug Therapy
44
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
44
01:26Psychosis: Goals of Pharmacotherapy
131
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
131
01:54The Placebo Effect
6.2K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.2K
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
391
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
391